Jiangsu Hengrui Medicine (600276.SS) Dividends
Market Cap: $314.93B
Avg Volume: 48.59M
Industry: Drug Manufacturers - General
Sector: Healthcare
Dividend Overview
Jiangsu Hengrui Medicine (600276.SS) pays a annual dividend to its shareholders. The current dividend yield is 0.48%, which means that for every $100 invested at the current price, investors would receive approximately $0.48 in dividends per year (this can change based on future dividend payments and price movements).
About 600276.SS's Dividend
Jiangsu Hengrui Medicine pays a annual dividend. The total annual dividend is approximately $0.20 per share, meaning for each share you own, you'll receive about $0.20 in dividends over the course of a year.
The most recent ex-dividend date was July 12, 2024. If you purchase the stock before its ex-dividend date, you'll be eligible for the upcoming dividend payment.
Jiangsu Hengrui Medicine 's payout ratio is 0.20% which means that 0.20% of the company's earnings are paid out as dividends. A low payout ratio indicates that the company has a strong financial position and can invest in growth opportunities, while maintaining room to increase dividends in the future.
Jiangsu Hengrui Medicine 's dividend has decreased by -0.25% over the past year. A decrease in dividends can occur for various reasons, including changes in financial situation or strategic priorities.
600276.SS Dividend History
| Dividend | Yield | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.2 | 0.48% | July 12, 2024 | July 11, 2024 | July 12, 2024 | |
| $0.16 | 0.35% | June 08, 2023 | June 07, 2023 | June 08, 2023 | |
| $0.16 | 0.39% | July 05, 2022 | July 04, 2022 | July 05, 2022 | |
| $0.16667 | 0.23% | June 10, 2021 | June 09, 2021 | June 10, 2021 | |
| $0.23 | 0.24% | May 25, 2020 | May 22, 2020 | May 25, 2020 | |
| $0.22 | 0.28% | March 28, 2019 | March 27, 2019 | March 28, 2019 | |
| $0.292 | 0.30% | May 30, 2018 | May 29, 2018 | May 30, 2018 | |
| $0.135 | 0.27% | May 31, 2017 | May 26, 2017 | May 31, 2017 | |
| $0.1 | 0.26% | June 16, 2016 | |||
| $0.1 | 0.20% | June 15, 2015 | |||
| $0.09 | 0.38% | May 15, 2014 | |||
| $0.08 | 0.39% | June 07, 2013 | |||
| $0.09 | 0.46% | May 29, 2012 | |||
| $0.1 | 0.30% | April 26, 2011 | |||
| $0.1 | 0.31% | March 17, 2010 | |||
| $0.1 | 0.35% | April 30, 2009 | |||
| $0.1 | 0.31% | April 11, 2008 | |||
| $0.1733 | 0.72% | April 02, 2007 | |||
| $0.1833 | 1.15% | July 18, 2006 | |||
| $0.16 | 1.92% | June 16, 2005 | |||
| $0.08 | 0.96% | May 28, 2004 | |||
| $0.08 | 0.96% | August 07, 2003 | |||
| $0.048 | 0.48% | May 21, 2002 | |||
| $0.104 | 0.80% | May 11, 2001 |
Dividend Growth
Jiangsu Hengrui Medicine (600276.SS) dividend payments have decreased -24.99% over the past year
Note: This growth rate represents the year-over-year growth in total dividends paid by the company, which may differ from the growth in dividends per share if the number of outstanding shares has changed.
Dividend Safety
Dividend safety refers to the ability of a company to continue paying its dividends to shareholders without interruption or reduction. A company with a high level of dividend safety is generally considered to have a strong financial position, with a consistent history of paying dividends and a low risk of default.
Key Safety Indicators for 600276.SS
- Dividend Payout Ratio: 0.20% Low risk
- Dividend & Capex Coverage Ratio: 2.29x Strong coverage
- Dividend Frequency: Annual
- Recent Dividend Growth: -0.25% Negative
What These Indicators Mean
A low payout ratio (typically less than 60%) indicates that a company has enough earnings to pay dividends and retain earnings to reinvest in the business. Jiangsu Hengrui Medicine 's payout ratio is 0.20% , which is very conservative and suggests strong dividend sustainability.
The Dividend & Capex Coverage Ratio of 2.29x indicates how well the company can cover both its dividend payments and capital expenditures from operating cash flows. This strong ratio above 1.5x indicates Jiangsu Hengrui Medicine can comfortably cover its dividends and necessary investments from its operating cash flow.
Jiangsu Hengrui Medicine 's dividend growth rate of -0.25% is negative, which may signal financial challenges or a shift in capital allocation priorities.
It is worth noting that dividend safety can change over time based on a company's financial performance, industry conditions, and management decisions. Regular monitoring of these metrics is recommended for dividend-focused investors.